Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...

Masimo said it received Food and Drug Administration approval for its Stork baby monitor for purchase without a prescription. The over-the-counter system offers the same pulse oximetry technology as ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...

It’s a baby (monitor) boom! Shortly after Owlet secured a long-awaited FDA clearance for its baby-monitoring “sock” equipped with pulse oximetry technology—which was followed just last month by ...

Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to ...

Diagnostics business unit News of the agreement sent Masimo’s Nasdaq-listed stock price up in value by more than 30 per cent, with the $180-per-share purchase price last achieved just under a year ago ...

Amsterdam, the Netherlands and Irvine California – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology in Anesthesia 2022 Annual Meeting, which ...